Vancouver, Canada

Andy Isamu Kokaji

This inventor holds 6 USPTO granted patents and 2 published patent applications, plus 5 CIPO patents and 4 EPO patents. Top assignees: Stemcell Technologies Inc., Stemcell Technologies Canada Inc.. Active years: 2018-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andy Isamu Kokaji. Retrieved from https://idiyas.com/inventor/andy-isamu-kokaji

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 100.0


 

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Andy Isamu Kokaji

Introduction

Andy Isamu Kokaji is a prominent inventor based in Vancouver, Canada. She has made significant contributions to the field of biotechnology, particularly in the activation and expansion of human T cells and NK cells. With a total of six patents to her name, her work has the potential to impact therapeutic approaches in immunology.

Latest Patents

Among her latest patents is the invention titled "Soluble antibody complexes for T cell or NK cell activation and expansion." This disclosure provides compositions and methods for the activation and expansion of human T cells or NK cells using soluble monospecific antibody complexes. Another notable patent is "Method for separating cells using immunorosettes and magnetic particles." This invention relates to methods for separating target cells from non-target cells using immunorosettes and magnetic particles. The method involves contacting a sample containing target cells and secondary targets, such as erythrocytes, with an antibody composition that allows immunorosettes of the target cells and the secondary targets to form. The sample is subsequently contacted with a second antibody composition that enables the binding of magnetic particles to the formed immunorosettes and free secondary targets. The immunorosettes and secondary targets labeled with magnetic particles are then separated from non-target cells using a magnetic field. The antibody composition optionally contains bifunctional antibodies or tetrameric antibody complexes.

Career Highlights

Throughout her career, Andy has worked with notable companies in the biotechnology sector. She has been associated with Stemcell Technologies Inc. and Stemcell Technologies Canada Inc., where she has contributed her expertise in developing innovative solutions for cell separation and activation.

Collaborations

(Section skipped due to space constraints.)

Conclusion

Andy Isamu Kokaji's innovative work in the field of biotechnology showcases her dedication to advancing medical science. Her patents reflect her commitment to improving therapeutic techniques and enhancing our understanding of immune cell functions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…